Published in Medical Letter on the CDC and FDA, April 29th, 2007
PEGINTRON is administered once weekly at an individualized dose according to a patient's weight and is the only pegylated interferon indicated in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.